MIDTERM PT. 4

Question 1

RADIOACTIVE PACKAGES SHOULD BE DELIVERED DIRECTLY TO ______ TO AVOID UNNECESSARY EXPOSURE TO PXNS AND STAFFS

Answer 1

HOT LABORATORY

Question 2

ONCE A RADIOACTIVE PACKAGE HAS BEEN RECEIVED, IT MUST BE MONITORED FOR CONTAMINATION WITHIN ___ HOURS FROM DELIVERY TIME

Answer 2

3

Question 3

-look for signs of damage
-using GM counter in mR/HR UNIT

Answer 3

DURING INSPECTION

Question 4

IS PERFORMED AT THE SURFACE OF THE PACKAGE AND AT 1 METER FROM THE PACKAGE

Answer 4

EXTERNAL SURVEY

Question 5

SWABBING AROUND THE SURFACE WITH COTTON BALL AND MEASURE THE POSSIBLE ACTIVITY IN THE WELL COUNTER

Answer 5

WIPE TEST

Question 6

SURFACE SURVEY:

EXPOSURE LIMITS= ___

Answer 6

< 200 mR/hr

Question 7

ACTIVITY AT 1M:

EXPOSURE LIMITS= ___

Answer 7

< 10 mR/hr

Question 8

WIPE TEST:

EXPOSURE LIMITS= ___

Answer 8

6600 dpm/ 300 cm^2

Question 9

Intravenous: __

Answer 9

veins

Question 10

intrathecal: ___

Answer 10

spinal canal

Question 11

Intraarterial: ___

Answer 11

artery

Question 12

the generator can be eluted or “milked” more than once per day after elution

Answer 12

Molybdenum/ Technicium 99m Generator

Question 13

the 66 hours half-life of Mo99 allows generator to be used for __ weeks

Answer 13

2

Question 14

means to wash out or extract

Answer 14

elute

Question 15

Molybdenum/ Technicium 99m Generator:

50%= __
75%=__
100%=__

Answer 15

4 hours
8.5 hours
23 hours

Question 16

the only desired radionuclide in the Mo99/Tc99m generator

Answer 16

Technicium 99m

Question 17

most common radionuclide contaminant

Answer 17

Mo99

Question 18

daughter element of TC99m

Answer 18

technicium 99

Question 19

daughter element of TC99

Answer 19

ruthenium 99

Question 20

BEFORE PREPARING OF RADIOPHARMACEUTICALS FOLLOWING STEPS MUST BE DONE TO ENSURE RADIATION SAFETY & POSSIBLE CONTAMINATION:

Answer 20

1. WEAR PERSONNEL MONITORING DEVICES
2. WEAR LABORATORY COAT AND DISPOSABLE CLEAN GLOVES
3. USE SYRINGE AND VIAL SHIELDS (LEAD POT) AS NECESSARY

Question 21

IS PLACED INSIDE A LEAD POT TO PREVENT UNNECESSARY RADIATION EXPOSURE DURING PREPARATION

Answer 21

PHARMACEUTICAL VIAL

Question 22

IS ADDED TO THE NON-RADIOACTIVE PHARMACEUTICAL VIAL ENCLOSED IN A LEADPOT

Answer 22

Tc-99m

Question 23

IS ADDED TO THE NON-RADIOACTIVE PHARMACEUTICAL VIAL ENCLOSED IN A LEADPOT

Answer 23

Tc-99m

Question 24

A RADIOPHARMACEUTICAL:

REQUIRES HEATING OF VIAL FOR 10 MINS AND 10 MINS COOLING OF VIAL AFTER HEATING

Answer 24

Tc99m MIBI

Question 25

A RADIOPHARMACEUTICAL:

REQUIRES GENTLE SWIRLING OF VIAL TO AVOID ACCUMULATION OF BUBBLES OR FOAM-LIKE TEXTURE DURING MIXTURE

Answer 25

Tc-99m MAA

Question 26

SECURE THE SYRINGE WITH A ___

Answer 26

LEAD SYRINGE SHIELD

Question 27

FOR ANATOMY

Answer 27

T1